Investing Profile

DanDan Dong

InvestorVC
Venture Partner at TCGX
Photo of DanDan Dong, Venture Partner at TCGX

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Fudan University Network
42 CONNECTIONS
VIVO Capital Network
11 CONNECTIONS
cb
TCGX Venture Partner
$10.0M - $50.0M
$25.0M
3
CompanyStageDateRound SizeTotal Raised
Visen Pharmaceuticals
Series BJan 2021$150M
Series ANov 2018$40M
$190M
Kira Pharmaceuticals
Series BJan 2021$54M
$100M
Co-investors: Nisa Leung (Qiming Venture Partners)
Part time consultant In-Vivo VenturesPresent
Part time consultant Vivo VenturesPresent
Managing Director VIVO CapitalPresent
Managing Director Vivo Capital Full-timePresent
Chief Business Officer, Board Member, Chair of JCC and JDC Member Visen PharmaceuticalsPresent
Board Member Visen PharmaceuticalsPresent
Chief Business Officer Visen PharmaceuticalsPresent
Chief Business Officer ArriVent BiopharmaPresent
Board Member InnoCare PharmaPresent
Co-founder and Board Member, Member of Transaction Committee RareStone GroupPresent
Venture Partner TCGXPresent
Sichuan University _Bachelor's degree Biotechnology
四川大学 _Bachelor's degree Biotechnology
Fudan University _Doctor of Philosophy (Ph.D.) Molecular Microbiology
New York University School of Medicine _Pre-doctor fellow Department of pathology